Evaluation of Platelet-Rich Plasma (PRP) Treatment in Tendinopathies
Recruiting
Observational Study
Patellar Tendinopathy
Achilles Tendinopathy (AT)
Epicondylitis, Lateral
Plantar Fasciitis, Chronic
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 2,000 (estimated)
- Sponsor
- ReSport Clinic · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This multicenter, prospective, observational study, based on real-world evidence (RWE), aims to evaluate the efficacy and safety of Platelet-Rich Plasma (PRP) treatment across four types of tendinopathies: patellar, Achilles, epicondylar, and plantar fasciosis. Data collection and analysis will be conducted using the BioSmartData® platform, including hematology analyzers for PRP characterization, …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Clinical and/or ultrasound diagnosis of chronic tendinopathy (duration \>6 weeks)
* Age \>18 years
* Provision of written informed consent
* Willingness and ability to complete follow-up assessments for 12 months
Exclusion Criteria:
* Surgical treatment of the affected tendo…
Contacts